Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mononegavirales Infections”

642 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 642 results

Not applicableStudy completedNCT01641315
What this trial is testing

Immunogenicity Study of a Reduced (4-dose) Vaccine Schedule and Rabies Immunoglobulins

Who this might be right for
Rabies
Queen Saovabha Memorial Institute 75
Not applicableEnded earlyNCT05105191
What this trial is testing

Analytical Performances and Clinical Impact of the Roche Cobas® Liat Influenza A/B & RSV Assay in the Management of Adult and Pediatric Patients Attending the Emergency Room

Who this might be right for
Influenza Viral InfectionsRSV Infection
Erasme University Hospital 280
Large-scale testing (Phase 3)Study completedNCT01346293
What this trial is testing

Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age

Who this might be right for
TetanusDiphtheriaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 3,372
Not applicableUnknownNCT05888649
What this trial is testing

Community Preparedness for Outbreak Response and Readiness for Ebola Vaccination in Liberia

Who this might be right for
Ebola Virus Disease
UL-PIRE Africa Center 1,500
Testing effectiveness (Phase 2)Study completedNCT05568706
What this trial is testing

EDP-938 in Non-hospitalized Adults With RSV Who Are at High Risk for Complications.

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 186
Not applicableStudy completedNCT05702008
What this trial is testing

Social Media as an Information, Education and Communication Tool for Rabies Prevention: An Interventional Study

Who this might be right for
RabiesHealth EducationPublic Health+1 more
Maulana Azad Medical College 300
Testing effectiveness (Phase 2)Study completedNCT04394689
What this trial is testing

Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial

Who this might be right for
MeaslesRubellaVaccination+1 more
Micron Biomedical, Inc 281
Early research (Phase 1)Ended earlyNCT02041715
What this trial is testing

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802

Who this might be right for
Ebola Virus Infection
Arbutus Biopharma Corporation 21
Large-scale testing (Phase 3)Study completedNCT05966090
What this trial is testing

A Study on Safety and Immune Response of Investigational RSV OA Vaccine in Combination With Herpes Zoster Vaccine in Healthy Adults

Who this might be right for
Respiratory Syncytial VirusesRespiratory Syncytial Virus Infections
GlaxoSmithKline 530
Testing effectiveness (Phase 2)Study completedNCT00232635
What this trial is testing

The Safety and Efficacy of A-60444 in Adults With Respiratory Syncytial Virus (RSV) Infection Following HSCT

Who this might be right for
Respiratory Syncytial Virus Infections
Arrow Therapeutics 27
Post-approval studies (Phase 4)Study completedNCT00432731
What this trial is testing

Safety Study of a Refrigerator-stable Formulation of VARIVAX®

Who this might be right for
VaricellaMeaslesMumps+1 more
Merck Sharp & Dohme LLC 500
Early research (Phase 1)Study completedNCT05178901
What this trial is testing

Evaluate Safety & Immunogenicity of RVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects

Who this might be right for
Nipah Virus Infection
Public Health Vaccines LLC 60
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Post-approval studies (Phase 4)Study completedNCT00260351
What this trial is testing

Immunogenicity and Safety of Verorab™ in Indian Population

Who this might be right for
Rabies
Sanofi Pasteur, a Sanofi Company 405
Early research (Phase 1)Study completedNCT00072605
What this trial is testing

Experimental Ebola Vaccine Trial

Who this might be right for
Hemorrhagic Fever, EbolaHealthy
National Institute of Allergy and Infectious Diseases (NIAID) 27
Testing effectiveness (Phase 2)Study completedNCT02360475
What this trial is testing

Safety, Reactogenicity and Immunogenicity Study of Different Formulations of GlaxoSmithKline (GSK) Biologicals' Investigational RSV Vaccine (GSK3003891A), in Healthy Women

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 507
Not applicableUnknownNCT02662595
What this trial is testing

MHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau

Who this might be right for
Measles
Bandim Health Project 1,050
Large-scale testing (Phase 3)Active Not RecruitingNCT06534892
What this trial is testing

An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 10,212
Testing effectiveness (Phase 2)Study completedNCT02718937
What this trial is testing

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Biota Pharma Europe Limited 60
Large-scale testing (Phase 3)Study completedNCT01702428
What this trial is testing

Consistency Study of GlaxoSmithKline (GSK) Biologicals' MMR Vaccine (209762) (Priorix) Comparing Immunogenicity and Safety to Merck & Co., Inc.'s MMR Vaccine (M-M-R II), in Children 12 to 15 Months of Age

Who this might be right for
RubellaMeaslesMumps
GlaxoSmithKline 5,016
Load More Results